Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

Overview of attention for article published in BMC Infectious Diseases, January 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Readers on

mendeley: 77 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 2 news stories from 1 outlets.

Novavax: Earnings Call Review And Assessment Of The Multi-Arm RSV Trial

Seeking Alpha, 09 May 2017

I had to undergo surgery a few months ago and the recovery wiped out most of my time, so it's taken me much longer than…

Novavax; Part 2: A Deep Dive Into Phase 3 Of Its RSV Vaccine For Older Adults

Seeking Alpha, 20 Sep 2016

After Thursday's close, Novavax (NASDAQ: NVAX ) announced its phase 3 trial of its vaccine to prevent RSV (respiratory…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.